Check out my new song "Scared of Tomorrow" and let me know what you think in the comments ❤️ The future is scary, the present can be painful at times, and it seems "things" can make the pain and anxiety go away but the only thing that can help is being comfortable with yourself, and truly believing you can do anything. https://audius.co/Hatty/scared-of-tomorrow "Am I weak if I need help for the pain?" - Scared of Tomorrow I wanted to thank everyone for coming over to my Discord. I had to cancel streams because I need to focus on getting a job and creating videos. I am still going to be doing Giveaways for my videos and I plan on starting some for my music as well. Also you get rewards for hanging out, you can not beat that (there is actually a giveaway going on right now 🙊). I do plan on doing streams in the future though. I have not given up. Just realized I need to change things up a little. Need time to think and organize something that will work for the long term. As time goes on I will talk more about this but for now going to work on getting my money up and being able to invest into Learn With Hatty. Right now I am working on adding Mr Grey to my videos. He is an animated Cat that talks about the topic I am discussing and shares important information. New video should be dropping in the next couple of days. Mr Grey is coming alive!!! X - https://x.com/hatty_hats Twitch - https://www.twitch.tv/hattyhatss Discord - https://discord.gg/UQqFRgzCkG YouTube - https://www.youtube.com/@hattyhats0 To the Future everyone ❤️🙏

✅ What are the rules? 🔹 Top 3 designs will win 1,000 ADA each. 🔹 Competition runs from July 29th to August 11th. 🔹 Winners will be announced thereafter. 🔹 Designs from winning entries may be adopted and used to inspire the design of the Cardano Card. For complete information, please check the X account thecardanocard ✅ #thecardanocard #cardanocard #changemakersnft #competition

Check out my latest video! The story of prisons is not just about crime, it’s about justice, power, money, and society. It’s about how we treat people at their lowest, and what that says about us. “From Punishment to Profit – The System No One Escapes” https://youtu.be/FQZnBmzV8ZU?si=9KRQnJJhfsjUkKZt

As the rally in technology stocks boosts market sentiment, investors continue to assess the impact of Trump's new tariffs. 🔹 S&P 500 futures: +0.3% 🔹 Nasdaq 100 futures: +0.3% 🔹 Dow futures: +0.2% 📊 Bond Market 10Y return: 4.26% (flat) 2Y return: +1bp ➡ 3.75% 📌 Thursday Summary S&P 500: -0.08% (Eli Lilly earnings pressured) Nasdaq: +0.35% 🆙 Mag-7: +0.40% 📈 (All-time high) 💬 Deutsche Bank – Jim Reid: “Trump’s chip tax exemptions and the easing of Russia-Ukraine tensions have tempered optimism. Tariffs have taken effect, but the market reaction has been weak.” 📰 Other Developments Trump tariffs officially began last night Fed Governor Waller is emerging as a candidate for chairman after Powell Today's data agenda is quiet; St. Louis Fed President Musalem will speak #SP500 #Nasdaq #DowJones #TrumpTariffs #BondMarket #Fed #Markets

$RXRX Analysts Confident in Recursion Pharmaceuticals' Future: Earnings Estimates Rising! 📈 Biotechnology company Recursion is on analysts' radars. The company's revenue is expected to jump from approximately $70.58 million this year to $113.91 million next year, a growth of over 61%. This strong growth outlook has analysts painting an optimistic outlook for the stock. The 25% revenue surpassing expectations in the last quarter was a major driver of this positive sentiment. Partnerships with industry giants like Sanofi, including a potential $300 million payout, also bolster confidence in the company's future revenue streams. The consensus rating from five analysts is "Buy," while the average price target for the stock is $7.00. This target suggests a potential upside of approximately 29% from the current price. The fact that the company has sufficient cash reserves until the last quarter of 2027 also demonstrates its financial resilience.

Hey everyone! I hope you are having a good week. I had a blast during last nights Marbles for @Cardano. Remember to join the fun every Mon, Wed, and Fri at 8:30pm EST! Join my Discord to earn rewards when I stream.
 Twitch - https://www.twitch.tv/hattyhatss Discord - https://discord.gg/UQqFRgzCkG

 I have a new video dropping in a couple days. This video is going to cover Prisons and the systems beings used against us for profit. Stay tuned and remember to follow me on YouTube to get notified when I post. 
 Learn With Hatty - https://www.youtube.com/@hattyhats0



$TSLA $INTC $TSM Tesla Switches to Intel Foundry and EMIB Technology for Dojo 3! Tesla's next-generation Dojo 3 supercomputer works with ultra-large chip modules. TSMC's System-on-Wafer (SoW) technology is insufficient to package these massive modules. Production lines are overwhelmed with CoWoS requests and cannot prioritize Tesla's special orders. Intel's EMIB (Embedded Multi-Die Interconnect Bridge) technology offers greater modularity, flexibility, and scalability, allowing Elon Musk to more aggressively develop the Dojo architecture. Therefore, Tesla is reducing its reliance on Taiwan Semiconductor by choosing Samsung for production and Intel for packaging due to TSMC's packaging limitations.

$HIMS Hims & Hers' Weight Loss Strategy Shakes Up Balance Sheet Metrics! 📉 Telehealth platform Hims & Hers surprised investors by missing Wall Street expectations for the first time, despite a 73% year-over-year increase in revenue to $544.8 million in the second quarter. This led to a 13% post-session drop in the stock. The primary reason behind this unexpected decline in figures is forced changes to the company's GLP-1 (weight loss) drug strategy. With the FDA's end of the semaglutide shortage, Hims was forced to change its sales model for more affordable generic GLP-1 drugs. This led to a decline in online GLP-1 revenue from $230 million in the first quarter to $190 million in the second quarter, and a decrease in average revenue per subscriber from $84 to $74. While the company achieved 31% year-over-year subscriber growth, reaching 2.4 million subscribers, uncertainties surrounding its GLP-1 strategy and developments such as the termination of its partnership with Novo Nordisk cast doubt on its growth narrative. Negative free cash flow is another concern. Hims & Hers will now attempt to navigate this challenging period by focusing on personalized GLP-1 therapies.

$RDW Redwire Corporation announced that its newly acquired subsidiary, Edge Autonomy, has been awarded a prototype phase contract by the U.S. Army under the Long-Range Reconnaissance (LRR) program. This development indicates that Edge Autonomy will play a more critical role in U.S. defense strategies with its Stalker unmanned aerial systems (UAS).

📊 $LLY | Eli Lilly Q2'25 Financial Results Strong Growth, Deepening Pipeline 🔹 Revenue: $15.56B (+38% YoY) 🟢 🔹 Adjusted EPS: $6.31 (+61% YoY) 🟢 🔹 Zepbound: $3.38B (+172%) 🔹 Mounjaro: $5.20B (+68%) 💡 Zepbound and Mounjaro solidify Eli Lilly's leadership in the metabolic diseases segment, with this quarter's results demonstrating momentum for both prescription penetration and patient acceptance of these products. 📌 FY25 guidance revised upward: ▫️ Revenue: $60–62B ▫️ Adj. EPS: $21.75–$23.00 🔬 Positive developments in the pipeline (Orforglipron, Jaypirca, Kisunla) present very strong catalysts that will support growth in the medium to long term. 💼 It also appears to be continuing its focus on innovation with the acquisitions of SiteOne and Verve Therapeutics and the Purdue collaboration. 📈 Comment: Eli Lilly is demonstrating not only strong sales growth but also a structural transformation. Supported by its leadership in the GLP-1 class, cardiometabolic protection data, and R&D investments, the pipeline offers a defensive and growth combination for long-term investors. #LLY #EliLilly #Balance Sheet #GLP1 #Zepbound #Mounjaro #HealthcareSector #StockAnalysis

🧠 $BMNR | The art of Ethereum accumulation, or a strategy lesson? 🔹 July 29: 625K $ETH purchased, avg: $3,755 🔹 August 4: Position increased to 833K ETH, avg cost $3,492 🔹 Was the new 208K ETH purchased at an average price of $2,702? ❗️Yet, spot ETH never fell below $3,380 during this period. ➡️So how did BMNR buy at such a low price? Answer: Could be forward agreements or structured derivatives contracts. ETH was around $2,500 during the "big bang" announcement at the end of June. Call rights were likely created at that time and are now being activated. This may be the reason for the recent surge in the stock: Investors are waking up to this strategic buying. If ETH additions continue at this rate, BMNR will be one of the few companies collecting below the spot price. Tommy L and his team may be making a very smart play. #ETH #Ethereum #BMNR #CryptoStocks #Blockchain #InvestmentStrategy #SmartMoney

🧠 DA Davidson downgrades $IONQ: 🔻 Buy → Neutral, target: $35 🗣️ Analyst: “The quantum revolution is coming, but IonQ’s short-term outlook is murky. The roadmap is unclear, and risks have increased.” 🚧 Investment continues, but visibility is low → A “stay on the sidelines” position has been adopted. ➡️ Long-term is exciting, short-term is a question mark... Not investment advice!!! #IONQ #QuantumComputing #Quantum #StockAnalysis #StockMarket